122 related articles for article (PubMed ID: 18782500)
1. RNA profiling of MS brain tissues.
Kinter J; Zeis T; Schaeren-Wiemers N
Int MS J; 2008 Jun; 15(2):51-8. PubMed ID: 18782500
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
Lindberg RL; Kappos L
Expert Rev Mol Diagn; 2006 Nov; 6(6):843-55. PubMed ID: 17140371
[TBL] [Abstract][Full Text] [Related]
3. Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis.
Mycko MP; Papoian R; Boschert U; Raine CS; Selmaj KW
Clin Neurol Neurosurg; 2004 Jun; 106(3):223-9. PubMed ID: 15177772
[TBL] [Abstract][Full Text] [Related]
4. Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology.
Weis S; Llenos IC; Dulay JR; Elashoff M; Martínez-Murillo F; Miller CL
J Neurosci Methods; 2007 Sep; 165(2):198-209. PubMed ID: 17628689
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.
Lindberg RL; De Groot CJ; Certa U; Ravid R; Hoffmann F; Kappos L; Leppert D
J Neuroimmunol; 2004 Jul; 152(1-2):154-67. PubMed ID: 15223248
[TBL] [Abstract][Full Text] [Related]
6. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.
Chabas D; Baranzini SE; Mitchell D; Bernard CC; Rittling SR; Denhardt DT; Sobel RA; Lock C; Karpuj M; Pedotti R; Heller R; Oksenberg JR; Steinman L
Science; 2001 Nov; 294(5547):1731-5. PubMed ID: 11721059
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
[TBL] [Abstract][Full Text] [Related]
8. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.
Satoh J; Nakanishi M; Koike F; Onoue H; Aranami T; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Saito T; Ohta M; Miyake S; Kanda T; Fukazawa T; Yamamura T
J Neuroimmunol; 2006 May; 174(1-2):108-18. PubMed ID: 16564577
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis therapy monitoring based on gene expression.
Goertsches R; Serrano-Fernández P; Möller S; Koczan D; Zettl UK
Curr Pharm Des; 2006; 12(29):3761-79. PubMed ID: 17073675
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in MS: what is the clinical relevance?
De Jager PL; Hafler DA
Lancet Neurol; 2004 May; 3(5):269. PubMed ID: 15099539
[No Abstract] [Full Text] [Related]
11. Multiple sclerosis and gene expression profiling.
Steinman L
Adv Exp Med Biol; 2001; 490():109-12. PubMed ID: 11505968
[No Abstract] [Full Text] [Related]
12. miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing.
Guerau-de-Arellano M; Alder H; Ozer HG; Lovett-Racke A; Racke MK
J Neuroimmunol; 2012 Jul; 248(1-2):32-9. PubMed ID: 22078708
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional analysis of targets in multiple sclerosis.
Steinman L; Zamvil S
Nat Rev Immunol; 2003 Jun; 3(6):483-92. PubMed ID: 12776208
[TBL] [Abstract][Full Text] [Related]
14. Gene profiling for defining targets for new therapeutics in autoimmune diseases.
Rogge L
Arthritis Res Ther; 2003; 5(2):47-50. PubMed ID: 12718743
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
Mycko MP; Brosnan CF; Raine CS; Fendler W; Selmaj KW
J Neurosci Res; 2012 Oct; 90(10):1941-8. PubMed ID: 22715030
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling in multiple sclerosis brain.
Dutta R; Trapp BD
Neurobiol Dis; 2012 Jan; 45(1):108-14. PubMed ID: 21147224
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
Zeis T; Kinter J; Herrero-Herranz E; Weissert R; Schaeren-Wiemers N
J Neuroimmunol; 2008 Dec; 205(1-2):10-9. PubMed ID: 18950873
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers.
Martinelli-Boneschi F; Fenoglio C; Brambilla P; Sorosina M; Giacalone G; Esposito F; Serpente M; Cantoni C; Ridolfi E; Rodegher M; Moiola L; Colombo B; De Riz M; Martinelli V; Scarpini E; Comi G; Galimberti D
Neurosci Lett; 2012 Feb; 508(1):4-8. PubMed ID: 22108567
[TBL] [Abstract][Full Text] [Related]
19. MS therapy research applying genome-wide RNA profiling of peripheral blood.
Goertsches R; Zettl UK
Int MS J; 2007 Sep; 14(3):98-107. PubMed ID: 18028834
[TBL] [Abstract][Full Text] [Related]
20. Genomics in multiple sclerosis--current state and future directions.
Comabella M; Martin R
J Neuroimmunol; 2007 Jul; 187(1-2):1-8. PubMed ID: 17400297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
